London, UK
Wed 09 10:20
OC5.7
A novel human disorder: QSOX2 deficiency-induced growth restriction, gastrointestinal dysmotility and immune dysfunction highlights a new mechanism of disease.
London, UK
Glasgow, UK
London, UK
Ormskirk, UK
Thu 10 10:00
Sheffield, UK
Thu 10 11:16
OC10.5
Single-centre review of use of Gonadotrophin-Releasing Hormone Agonists – are we outliers?
Sheffield, UK
Leeds, UK
Tue 08 10:00
OC1.1
Phenotypic diversity in siblings with a rare cause of Hypophosphataemic rickets
Leeds, UK
Glasgow, United Kingdom
Thu 10 12:55
Rare Disease Registries – Joining The Dots For Collaborative Research
Glasgow, United Kingdom
Liverpool, UK
Tue 08 12:00
OC2.1
Facial Asymmetry Revealing Hypothyroidism and Pituitary Hyperplasia in a Young Child
Liverpool, UK
Edinburgh, UK
Birmingham, UK
Wed 09 11:50
Sheffield, UK
Wed 09 10:00
OC5.5
Glucocorticoid replacement therapy in congenital adrenal hyperplasia and its associations with growth outcomes - real world data analysis from an international cohort of 1500 patients.
Sheffield, UK
Birmingham, UK
Wed 09 12:20
OC7.1
Does severity of DKA presentation associate with autoantibody status, deprivation or ethnicity - a two-centre retrospective cohort
Birmingham, UK
Manchester, UK
Birmingham
Birmingham, UK
London, UK
Wed 09 12:32
OC7.3
Glycaemic control of children and young people with Type 1 Diabetes fasting during Ramadan at a single London Paediatric Diabetes unit
London, UK
Glasgow, UK
Thu 10
A Guide to Growth Hormone Deficiency for New Endocrine Nurses
Glasgow, UK
Glasgow, UK
Thu 10 11:07
OC10.4
Education Of Sick Day Management Of Paediatric Adrenal Insufficiency: A National Survey Of Paediatric Endocrine Nurse Specialists
Glasgow, UK
Southampton, UK
Thu 10 11:00
OC9.3
Tackling health inequalities, engagement opportunities and metabolic management in young adults living with diabetes – Transition Safe and Sound (TraSS), an NHS England pilot.
Southampton, UK
London, UK
Wed 09 09:30
OC5.2
Minipuberty: A Golden Phase for Optimal Treatment. Recombinant Gonadotropin Therapy During Minipuberty in Males with Hypogonadotropic Hypogonadism: A Case Series
London, UK
Glasgow, UK
Thu 10 09:00
Prader Willi Syndrome - Role of MDT Clinic
Glasgow, UK
Glasgow, UK
Glasgow, UK
Glasgow, UK
Newcastle, UK
Wed 09
Glasgow, UK
Thu 10 11:50
CoMBAT Study: Clinical effects of Metformin on Bones in Adults with Type 1 diabetes mellitus (T1DM)
Glasgow, UK
Glasgow, UK
Thu 10 09:00
Prader Willi Syndrome - Role of MDT Clinic
Glasgow, UK
Glasgow, UK
Glasgow, UK
Glasgow, UK
Barnsley, UK
Thu 10 11:30
OC9.6
Does admission for stabilisation affect HbA1c? A Single Trust Study
Barnsley, UK
Chertsey, UK
Tue 08 16:15
OC4.2
An Unusual Presentation of Paediatric Sarcoidosis
Chertsey, UK
Chertsey, UK
London, UK
Wed 09 09:40
OC5.3
Crinecerfont in Children and Adolescents with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency: Results from the Phase 3 CAHtalyst Pediatric Study
London, UK
Cardiff, Wales
London , UK
Sheffield, UK
Thu 10 14:40
Liverpool, UK
Thu 10 10:49
OC10.2
The effect of lifestyle and pharmacological interventions on body composition in childhood obesity
Liverpool, UK
Glasgow, UK
Wed 09 12:20
OC6.1
DXA lean mass index as a predictor of loss of ambulation in Duchenne Muscular Dystrophy and potential biomarker to initiate osteoporosis therapy prior to fractures
Glasgow, UK
Newcastle, UK
Wed 09 16:21
OC8.2
Thyroid dysfunction in patients diagnosed with neuroblastoma who received MIBG scans.
Newcastle, UK
Newcastle, UK
Cardiff`, UK
Wed 09 12:26
OC6.2
BSPED Audit of Clinical Standards for Differences of Sexual Development (DSD)
Cardiff`, UK
Cumbria, UK
Thu 10 10:50
OC9.2
Improving access to diabetes technology for CYP with Diabetes across NENC: a response to Poverty Proofing, the National Paediatric Diabetes Audit and the NHSE CORE20PLUS5.
Cumbria, UK
Glasgow, UK
Bristol, UK
Cardiff, UK
Hull, UK
Thu 10 11:40
OC9.7
Improving equity of care within a paediatric diabetes service
Hull, UK
Southampton, UK
Wed 09 10:10
OC5.6
Diagnostic testing using gene panels for severe childhood growth failure and multiple pituitary hormone deficiency in England
Southampton, UK
Southampton, UK
Bristol, UK
Thu 10 12:00
OC9.9
Young People and Parent or Carers Views on Type 2 Diabetes Mellitus Care in England and Wales – insights from the PREM survey report
Bristol, UK
Thu 10 10:40
OC10.1
Health-related quality of life in severe obesity: Baseline PedsQL scores from two tier 3 paediatric weight management services
Bristol, UK
Thu 10 11:40
Establishing the incidence, prevalence and clinical features of ROHHAD syndrome in the UK
Bristol, UK
Glasgow, UK
Wed 09 16:39
OC8.5
The effect of CFTR modulators on growth, body composition and bone health in children and adolescents with cystic fibrosis
Glasgow, UK
Cambridge, UK
London, UK
Wed 09 09:20
OC5.1
BRINP2 Gene Variants are Implicated in Severe Delayed Puberty Associated with Neurodevelopmental Phenotypes
London, UK
Glasgow, UK
Chertsey, UK
Tue 08 16:15
OC4.2
An Unusual Presentation of Paediatric Sarcoidosis
Chertsey, UK
Chertsey, UK
London, UK
Wed 09 12:44
OC6.5
Rare causes of Silver-Russell Syndrome frequently present with atypical features highlighting important implications for genetic testing and clinical management
London, UK
London, UK
Wed 09 16:15
OC8.1
A RETROSPECTIVE ANALYSIS OF ANTI-TPO RESULTS IN INFANTS WITH AN ABNORMAL CONGENITAL HYPOTHYROIDISM NEONATAL SCREENING
London, UK
Southampton, UK
Wed 09 16:33
OC8.4
Impact of specialist psychology provision and outcomes for a DSD service
Southampton, UK
Southampton, UK
Wed 09 10:10
OC5.6
Diagnostic testing using gene panels for severe childhood growth failure and multiple pituitary hormone deficiency in England
Southampton, UK
Southampton, UK
Glasgow, UK
Glasgow, UK
Cambridge, UK
Newcastle, UK
Wed 09 16:21
OC8.2
Thyroid dysfunction in patients diagnosed with neuroblastoma who received MIBG scans.
Newcastle, UK
Newcastle, UK
Belfast, UK
Thu 10 11:25
OC10.6
Audit of Pituitary Dysfunction Post Moderate to Severe Traumatic Brain Injury and Proposed Surveillance Guidance
Belfast, UK
Glasgow, UK
Tue 08 14:30
OC3.1
Phenotypic features of two brothers with a rare X-linked insulin receptor substrate 4 (IRS4) mutation and the suspected role of IRS4 in the HPT axis
Glasgow, UK
London, UK
Wed 09 12:38
OC6.4
Low-level chromosomal mosaicism does not explain the spontaneous menarche seen in some women with 45,X Turner Syndrome
London, UK
Glasgow , UK
Belfast, UK
Tue 08 12:15
OC2.2
16 Years of Learning: The First Patient Treated with Asfotase Alfa for Perinatal Hypophosphatasia
Belfast, UK
Glasgow, UK
Wed 09 12:32
OC6.3
Systematic review of cardiometabolic outcomes in young people with gender dysphoria and the impact of puberty blockers
Glasgow, UK
Liverpool, UK
Tue 08 14:00
Edinburgh, UK
Birmingham, UK
Thu 10 10:40
OC9.1
Award-Winning Virtual Schools Training Package Creates Capacity to Enable 78% of Children to Access Hybrid Closed Loop Therapy
Birmingham, UK
Glasgow, UK
Thu 10 11:20
OC9.5
Socioeconomic status influencing the cessation of insulin pump therapy in children with Type 1 Diabetes: a cohort study
Glasgow, UK
Manchester, UK
Thu 10 12:00
Presentation Title TBC
Manchester, UK
Birmingham, UK
Edinburgh , UK
Stevenage, UK
Tue 08 10:15
OC1.2
A case of Kearns-Sayer Syndrome Presenting with Hypoglycaemia and Adrenal Insufficiency
Stevenage, UK
Birmingham, UK
Wed 09 12:44
OC7.5
Comparison of glycaemic control across different ethnic and socioeconomic groups in a cohort of children using hybrid closed loop systems
Birmingham, UK
Coventry, UK
Wed 09 12:26
OC7.2
A regional audit of Diabetic Ketoacidosis (DKA) presentations at diagnosis of type 1 diabetes (T1DM) and DKA management.
Coventry, UK
Cardiff, UK
Thu 10 11:50
OC9.8
Understanding the lived experiences of the development and maintenance of Disordered Eating Behaviours (DEB) in Type 1 Diabetes (T1D) in paediatric diabetes care
Cardiff, UK
London, UK
Wed 09 12:38
OC7.4
Short term outcomes for children with new onset diabetes and confirmed SARS-CoV-2 Infections – a case series
London, UK
London, UK
Glasgow, UK
Tue 08 16:00
OC4.1
Reassessing Pancreatectomy in Diffuse Congenital Hyperinsulinism: A Tale of Two Brothers with Homozygous KCNJ11 Variants
Glasgow, UK
Nottingham, UK
Wed 09 10:40
OC5.9
Genomic diagnoses in DSDs – 10-year experience from a regional DSD service
Nottingham, UK
Nottingham, UK
Portsmouth, UK
Wed 09 16:27
OC8.3
Psychological and social characteristics of children and young people living with obesity in Portsmouth and Southampton
Portsmouth, UK
Oxford, UK
Birmingham, UK
Wed 09 09:50
OC5.4
Premature Adrenarche, Body Composition and Metabolic Dysfunction – A Pilot Study
Birmingham, UK
Birmingham, UK
Glasgow, UK
Thu 10 12:25
Obesity and metabolic syndrome - what can paediatricians learn from our adult colleagues?
Glasgow, UK
Cambridge, UK
Tue 08 11:00
Interpretation of abnormal thyroid function tests in children and adoloscents
Cambridge, UK
University of Cambridge, Cambridge, UK
Tue 08 13:30
Insulin resistance-mechanisms, conditions and management
University of Cambridge, Cambridge, UK
Bristol, UK
Wed 09 09:50
Glasgow, UK
Thu 10 09:00
Prader Willi Syndrome - Role of MDT Clinic
Glasgow, UK
Glasgow, UK
Glasgow, UK
Glasgow, UK
Glasgow, UK
Thu 10 09:00
Prader Willi Syndrome - Role of MDT Clinic
Glasgow, UK
Glasgow, UK
Glasgow, UK
Glasgow, UK
Glasgow, UK
Thu 10 10:58
OC10.3
Increased Prevalence of Hypertension in Paediatric Turner Syndrome
Glasgow, UK
Nottingham, UK
Wed 09 10:40
OC5.9
Genomic diagnoses in DSDs – 10-year experience from a regional DSD service
Nottingham, UK
Nottingham, UK
Liverpool, United Kingdom
Newcastle, UK
Wed 09 10:30
OC5.8
Oral risedronate therapy in Duchenne muscular dystrophy: The John Walton Muscular Dystrophy Centre Experience
Newcastle, UK
Oxford, UK
Thu 10 11:10
OC9.4
Working Above and Below the Lines: Paediatric diabetes health care professionals’ experiences of safeguarding and child protection.
Oxford, UK
Workshop
0
Oral
0
Expert
0
Plenary
0
Catering and Social
0
Nurse
0
Other
0
Symposium
0
No Session Type
59
Tue 08 10:00
OC1.1
Phenotypic diversity in siblings with a rare cause of Hypophosphataemic rickets
Leeds, UK
Tue 08 10:15
OC1.2
A case of Kearns-Sayer Syndrome Presenting with Hypoglycaemia and Adrenal Insufficiency
Stevenage, UK
Tue 08 11:00
Interpretation of abnormal thyroid function tests in children and adoloscents
Cambridge, UK
Tue 08 12:00
OC2.1
Facial Asymmetry Revealing Hypothyroidism and Pituitary Hyperplasia in a Young Child
Liverpool, UK
Tue 08 12:15
OC2.2
16 Years of Learning: The First Patient Treated with Asfotase Alfa for Perinatal Hypophosphatasia
Belfast, UK
Tue 08 13:30
Insulin resistance-mechanisms, conditions and management
University of Cambridge, Cambridge, UK
Tue 08 14:00
Tue 08 14:30
OC3.1
Phenotypic features of two brothers with a rare X-linked insulin receptor substrate 4 (IRS4) mutation and the suspected role of IRS4 in the HPT axis
Glasgow, UK
Tue 08 16:00
OC4.1
Reassessing Pancreatectomy in Diffuse Congenital Hyperinsulinism: A Tale of Two Brothers with Homozygous KCNJ11 Variants
Glasgow, UK
Tue 08 16:15
OC4.2
An Unusual Presentation of Paediatric Sarcoidosis
Chertsey, UK
Chertsey, UK
Wed 09 09:20
OC5.1
BRINP2 Gene Variants are Implicated in Severe Delayed Puberty Associated with Neurodevelopmental Phenotypes
London, UK
Wed 09 09:30
OC5.2
Minipuberty: A Golden Phase for Optimal Treatment. Recombinant Gonadotropin Therapy During Minipuberty in Males with Hypogonadotropic Hypogonadism: A Case Series
London, UK
Wed 09 09:40
OC5.3
Crinecerfont in Children and Adolescents with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency: Results from the Phase 3 CAHtalyst Pediatric Study
London, UK
Wed 09 09:50
OC5.4
Premature Adrenarche, Body Composition and Metabolic Dysfunction – A Pilot Study
Birmingham, UK
Wed 09 10:00
OC5.5
Glucocorticoid replacement therapy in congenital adrenal hyperplasia and its associations with growth outcomes - real world data analysis from an international cohort of 1500 patients.
Sheffield, UK
Wed 09 10:10
OC5.6
Diagnostic testing using gene panels for severe childhood growth failure and multiple pituitary hormone deficiency in England
Southampton, UK
Southampton, UK
Wed 09 10:20
OC5.7
A novel human disorder: QSOX2 deficiency-induced growth restriction, gastrointestinal dysmotility and immune dysfunction highlights a new mechanism of disease.
London, UK
Wed 09 10:30
OC5.8
Oral risedronate therapy in Duchenne muscular dystrophy: The John Walton Muscular Dystrophy Centre Experience
Newcastle, UK
Wed 09 10:40
OC5.9
Genomic diagnoses in DSDs – 10-year experience from a regional DSD service
Nottingham, UK
Nottingham, UK
Wed 09 09:50
Wed 09 11:50
Wed 09 12:20
OC6.1
DXA lean mass index as a predictor of loss of ambulation in Duchenne Muscular Dystrophy and potential biomarker to initiate osteoporosis therapy prior to fractures
Glasgow, UK
Wed 09 12:26
OC6.2
BSPED Audit of Clinical Standards for Differences of Sexual Development (DSD)
Cardiff`, UK
Wed 09 12:32
OC6.3
Systematic review of cardiometabolic outcomes in young people with gender dysphoria and the impact of puberty blockers
Glasgow, UK
Wed 09 12:38
OC6.4
Low-level chromosomal mosaicism does not explain the spontaneous menarche seen in some women with 45,X Turner Syndrome
London, UK
Wed 09 12:44
OC6.5
Rare causes of Silver-Russell Syndrome frequently present with atypical features highlighting important implications for genetic testing and clinical management
London, UK
Wed 09 12:20
OC7.1
Does severity of DKA presentation associate with autoantibody status, deprivation or ethnicity - a two-centre retrospective cohort
Birmingham, UK
Wed 09 12:26
OC7.2
A regional audit of Diabetic Ketoacidosis (DKA) presentations at diagnosis of type 1 diabetes (T1DM) and DKA management.
Coventry, UK
Wed 09 12:32
OC7.3
Glycaemic control of children and young people with Type 1 Diabetes fasting during Ramadan at a single London Paediatric Diabetes unit
London, UK
Wed 09 12:38
OC7.4
Short term outcomes for children with new onset diabetes and confirmed SARS-CoV-2 Infections – a case series
London, UK
Wed 09 12:44
OC7.5
Comparison of glycaemic control across different ethnic and socioeconomic groups in a cohort of children using hybrid closed loop systems
Birmingham, UK
Wed 09 16:15
OC8.1
A RETROSPECTIVE ANALYSIS OF ANTI-TPO RESULTS IN INFANTS WITH AN ABNORMAL CONGENITAL HYPOTHYROIDISM NEONATAL SCREENING
London, UK
Wed 09 16:21
OC8.2
Thyroid dysfunction in patients diagnosed with neuroblastoma who received MIBG scans.
Newcastle, UK
Newcastle, UK
Wed 09 16:27
OC8.3
Psychological and social characteristics of children and young people living with obesity in Portsmouth and Southampton
Portsmouth, UK
Wed 09 16:33
OC8.4
Impact of specialist psychology provision and outcomes for a DSD service
Southampton, UK
Wed 09 16:39
OC8.5
The effect of CFTR modulators on growth, body composition and bone health in children and adolescents with cystic fibrosis
Glasgow, UK
Wed 09
Thu 10 10:00
Thu 10 09:00
Prader Willi Syndrome - Role of MDT Clinic
Glasgow, UK
Glasgow, UK
Glasgow, UK
Glasgow, UK
Thu 10
A Guide to Growth Hormone Deficiency for New Endocrine Nurses
Glasgow, UK
Thu 10 10:40
OC9.1
Award-Winning Virtual Schools Training Package Creates Capacity to Enable 78% of Children to Access Hybrid Closed Loop Therapy
Birmingham, UK
Thu 10 10:50
OC9.2
Improving access to diabetes technology for CYP with Diabetes across NENC: a response to Poverty Proofing, the National Paediatric Diabetes Audit and the NHSE CORE20PLUS5.
Cumbria, UK
Thu 10 11:00
OC9.3
Tackling health inequalities, engagement opportunities and metabolic management in young adults living with diabetes – Transition Safe and Sound (TraSS), an NHS England pilot.
Southampton, UK
Thu 10 11:10
OC9.4
Working Above and Below the Lines: Paediatric diabetes health care professionals’ experiences of safeguarding and child protection.
Oxford, UK
Thu 10 11:20
OC9.5
Socioeconomic status influencing the cessation of insulin pump therapy in children with Type 1 Diabetes: a cohort study
Glasgow, UK
Thu 10 11:30
OC9.6
Does admission for stabilisation affect HbA1c? A Single Trust Study
Barnsley, UK
Thu 10 11:40
OC9.7
Improving equity of care within a paediatric diabetes service
Hull, UK
Thu 10 11:50
OC9.8
Understanding the lived experiences of the development and maintenance of Disordered Eating Behaviours (DEB) in Type 1 Diabetes (T1D) in paediatric diabetes care
Cardiff, UK
Thu 10 12:00
OC9.9
Young People and Parent or Carers Views on Type 2 Diabetes Mellitus Care in England and Wales – insights from the PREM survey report
Bristol, UK
Thu 10 10:40
OC10.1
Health-related quality of life in severe obesity: Baseline PedsQL scores from two tier 3 paediatric weight management services
Bristol, UK
Thu 10 10:49
OC10.2
The effect of lifestyle and pharmacological interventions on body composition in childhood obesity
Liverpool, UK
Thu 10 10:58
OC10.3
Increased Prevalence of Hypertension in Paediatric Turner Syndrome
Glasgow, UK
Thu 10 11:07
OC10.4
Education Of Sick Day Management Of Paediatric Adrenal Insufficiency: A National Survey Of Paediatric Endocrine Nurse Specialists
Glasgow, UK
Thu 10 11:16
OC10.5
Single-centre review of use of Gonadotrophin-Releasing Hormone Agonists – are we outliers?
Sheffield, UK
Thu 10 11:25
OC10.6
Audit of Pituitary Dysfunction Post Moderate to Severe Traumatic Brain Injury and Proposed Surveillance Guidance
Belfast, UK
Thu 10 11:40
Establishing the incidence, prevalence and clinical features of ROHHAD syndrome in the UK
Bristol, UK
Thu 10 11:50
CoMBAT Study: Clinical effects of Metformin on Bones in Adults with Type 1 diabetes mellitus (T1DM)
Glasgow, UK
Thu 10 12:00
Presentation Title TBC
Manchester, UK
Thu 10 12:25
Obesity and metabolic syndrome - what can paediatricians learn from our adult colleagues?
Glasgow, UK
Thu 10 12:55
Rare Disease Registries – Joining The Dots For Collaborative Research
Glasgow, United Kingdom
Thu 10 14:40
0 result(s) found.